Shichun Lu

3.9k total citations
97 papers, 1.5k citations indexed

About

Shichun Lu is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Shichun Lu has authored 97 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hepatology, 43 papers in Surgery and 37 papers in Epidemiology. Recurrent topics in Shichun Lu's work include Liver Disease Diagnosis and Treatment (23 papers), Hepatitis B Virus Studies (20 papers) and Hepatocellular Carcinoma Treatment and Prognosis (19 papers). Shichun Lu is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Hepatitis B Virus Studies (20 papers) and Hepatocellular Carcinoma Treatment and Prognosis (19 papers). Shichun Lu collaborates with scholars based in China, United States and Philippines. Shichun Lu's co-authors include Hongkui Deng, Chen Wu, Xiaolei Yin, Mingxiao Ding, Jun Cai, Xijun Song, Qin Han, Jun Yong, Dongxin Zhao and Yushan Guo and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Shichun Lu

89 papers receiving 1.5k citations

Peers

Countries citing papers authored by Shichun Lu

Since Specialization

Citations

This map shows the geographic impact of Shichun Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shichun Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shichun Lu more than expected).

Fields of papers citing papers by Shichun Lu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shichun Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shichun Lu. The network helps show where Shichun Lu may publish in the future.

Co-authorship network of co-authors of Shichun Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Shichun Lu. A scholar is included among the top collaborators of Shichun Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shichun Lu. Shichun Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	miR-141-3p-loaded extracellular vesicles ameliorate intrahepatic bile duct stone disease by decreasing MUC5AC expression <i>via</i> the MAPK pathway 2024 ·Intractable & Rare Diseases Research ·(unknown), Shichun Lu, Haowen Tang	1
2	Integrative multi-omics analysis reveals the role of tumor-associated endothelial cells and their signature in prognosis of intrahepatic cholangiocarcinoma 2024 ·Journal of Translational Medicine ·(unknown), (unknown), (unknown), Yafei Wang, (unknown), Junfeng Li, (unknown), (unknown), Xianzhou Zhang, Chonghui Li, Shichun Lu	4
3	Analysis of different surgical approaches to the treatment of thymoma 2024 ·Journal of Cardiothoracic Surgery ·Han Ma, Shichun Lu, (unknown), Xiaolin Wang, Yusheng Shu, (unknown)	0
4	The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy 2023 ·Frontiers in Immunology ·(unknown), Wenwen Zhang, (unknown), Zhanbo Wang, Jiajin Liu, Xiaodan Xu, Jinming Zhang, Baixuan Xu, Shichun Lu, Ruimin Wang, Guangyu Ma	3
5	Tumor‐derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients 2023 ·Cancer Medicine ·Lina Zhao, (unknown), Yulin Sun, Qiang Ju, Hong Mu, Xiu Rong Dong, Jing Ding, (unknown), (unknown), Li‐Ying Sun, Jianxiong Wu, Yuchen Jiao, Shichun Lu, Xiaohang Zhao	12
6	Comparison of survival benefit between salvage surgery after conversion therapy versus surgery alone for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity score analysis 2023 ·HPB ·(unknown), Haowen Tang, Bingyang Hu, Wenwen Zhang, Tao Wan, Jun Han, (unknown), Junfeng Li, Xuerui Li, (unknown), Zhe Liu, Minggen Hu, (unknown), Chenggang Li, Zhiming Zhao, Shichun Lu	11
7	Establishment and validation of exhausted CD8+ T cell feature as a prognostic model of HCC 2023 ·Frontiers in Immunology ·(unknown), (unknown), Lulu Liu, (unknown), Yafei Wang, Ming Gong, Chonghui Li, (unknown), Shichun Lu	8
8	Plant‐Inspired Multifunctional Bioadhesives with Self‐Healing Adhesion Strength to Promote Wound Healing 2022 ·Advanced Materials Interfaces ·Yazhong Bu, Wenwen Zhang, Sergio Martín‐Saldaña, Amir M. Alsharabasy, (unknown), (unknown), Ze Zhang, (unknown), Chonghui Li, Shichun Lu, Abhay Pandit	12
9	Proteome expression profiling of red blood cells during the tumorigenesis of hepatocellular carcinoma 2022 ·PLoS ONE ·Shufang Wang, Guibin Wang, Shichun Lu, Jiaying Zhang, Wenwen Zhang, Yuanyuan Han, Xiaoyu Cai, Yuan Zhuang, Fei Pu, Xin Yan, (unknown), Liang Wang, (unknown), Bin Fan, Deqing Wang, Zhaojun Zhang	2
10	Pretreatment Metabolic Parameters Measured by 18F-FDG PET to Predict the Pathological Treatment Response of HCC Patients Treated With PD-1 Inhibitors and Lenvatinib as a Conversion Therapy in BCLC Stage C 2022 ·Frontiers in Oncology ·(unknown), Wenwen Zhang, Jiaxin Chen, (unknown), Zhanbo Wang, Yanmei Wang, Xiaodan Xu, (unknown), (unknown), Jiahe Tian, Shichun Lu, Baixuan Xu, Guangyu Ma	9
11	174P A real-world study of PD-1 inhibitors combined with TKIs for HCC with major vascular invasion as the conversion therapy: A prospective, non-randomized, open-label cohort study 2020 ·Annals of Oncology ·(unknown), (unknown), Jun Han, Hui Wang, (unknown), (unknown), (unknown), (unknown), Shouwang Cai, (unknown), Junning Cao, (unknown), Shichun Lu	13
12	Clinical predictors of small solitary hepatitis B virus‐related hepatocellular carcinoma microinvasion 2019 ·ANZ Journal of Surgery ·Wenping Lu, Haowen Tang, (unknown), Kai Jiang, Yongliang Chen, Shichun Lu	1
13	Gastrointestinal: Situs inversus totalis with esophageal cancer 2019 ·Journal of Gastroenterology and Hepatology ·Qingbo Feng, Jie Yao, Shichun Lu	2
14	Essentials of precision medicine in practice of surgical oncology for hepatobiliary tumors 2019 ·Zhonghua gan-dan waike zazhi ·Shichun Lu	0
15	Risk factors for and management of ischemic-type biliary lesions following orthotopic liver transplantation: A single center experience 2015 ·Annals of Hepatology ·(unknown), Chuanyun Li, (unknown), Yuan Liu, Lu Wang, Shichun Lu	6
16	Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. 2009 ·PubMed ·Hongcan Shi, (unknown), Yusheng Shu, Weiping Shi, Shichun Lu, Kang Wang	12
17	Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells 2009 ·Cell Research ·Zhihua Song, Jun Cai, Yanxia Liu, Dongxin Zhao, Jun Yong, Shuguang Duo, Xijun Song, Yushan Guo, Yang Zhao, Qin Han, Xiaolei Yin, Chen Wu, (unknown), Shichun Lu, Mingxiao Ding, Hongkui Deng	369
18	Emergent right lobe adult-to-adult living-donor liver transplantation for high model for end-stage liver disease score severe hepatitis 2009 ·Transplant International ·Shichun Lu, Menglong Wang, Ning Li, (unknown), Ping Chi, Jinning Liu, Jun Dai, Zhen Zhang, (unknown), Dongdong Lin, Qingliang Guo, (unknown)	8
19	Energy Metabolism in Patients with End-stage Liver Disease before and after Liver Transplantation 2008 ·Shichun Lu	1
20	Prophylaxis of Recurrent Hepatitis B in Chinese Patients After Liver Transplantation Using Lamivudine Combined With Hepatitis B Immune Globulin According to the Titer of Antibody to Hepatitis B Surface Antigen 2007 ·Transplantation Proceedings ·Zuoyi Jiao, L.-N. Yan, (unknown), Yong Zeng, Tianfu Wen, Shichun Lu, Jichun Zhao, Weilong Wang, Mingqing Xu, Jiayin Yang, Yukui Ma, (unknown)	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact